Research Article
Clinical Characteristics of COVID-19 Patients with and without Diabetes in Wuhan Red Cross Hospital
Table 2
Laboratory findings of patients with COVID-19 at admission.
| | | | Median (IQR) | | value | | Normal range | Total () | Diabetic () | Nondiabetic () |
| | White blood cell count (×109/L) | 3.7-10 | 5.6 (4.1-7.0) | 6.0 (4.4-7.9) | 5.3 (4.1-6.5) | 0.011 | | Lymphocyte count (×109/L) | 0.80-4.00 | 1.17 (0.80-1.61) | 1.11 (0.73-1.42) | 1.19 (0.84-1.73) | 0.036 | | Prothrombin time (s) | 9-13 | 12.2 (11.5-13.2) | 12.3 (11.7-13.4) | 12.2 (11.4-13.1) | 0.430 | | Activated partial thromboplastin time (s) | 20-40 | 26.4 (22.9-31.0) | 25.8 (21.9-30.1) | 26.7 (23-31.6) | 0.105 | | D-dimer (mg/L) | 0-0.55 | 0.62 (0.33-1.68) | 0.96 (0.54-2.89) | 0.50 (0.26-1.22) | ≤0.001 | | Total bilirubin (mmol/L) | 2-25 | 8.4 (5.9-13.2) | 9.8 (7.0-14.6) | 7.5 (5.8-11.2) | 0.030 | | Albumin (g/L) | 35-55 | 36.5 (33.5-40.2) | 35.2 (31.9-38.3) | 37.7 (34.7-40.7) | 0.002 | | Blood urea nitrogen (mmol/L) | 2.6-7.5 | 4.3 (3.3-6.5) | 4.9 (3.5-7.8) | 4.3 (3.3-5.5) | 0.022 | | Creatinine (μmol/L) | 41-73 | 69.3 (55.1-83.5) | 70.7 (55.3-84.0) | 68.5 (55.1-83.5) | 0.643 | | Serum potassium | 3.5-5.5 | 3.77 (3.40-4.10) | 3.75 (3.40-4.13) | 3.77 (3.44-4.08) | 0.587 | | Fasting plasma glucose | 3.6-6.11 | 5.93 (5.03-7.80) | 7.92 (6.54-10.19) | 5.37(4.94-5.93) | ≤0.001 | | Oxygen saturation | >93% | 97% (95-98%) | 96% (93-97%) | 97% (95-98%) | ≤0.001 |
|
|
COVID-19: coronavirus disease 2019; IQR: interquartile range; No.: number.
|
